De­spite all the noise around up­com­ing mas­sive IPOs for AI gi­ants, a drug de­vel­op­er was able to at­tract enough in­vestor in­ter­est to achieve the biggest Nas­daq de­but the bio­phar­ma in­dus­try has ever seen...